1) The process starts with a boron-containing drug, administered to the body and then accumulating selectively in cancer cells. 2) A neutron beam applied to the affected area interacts with the boron accumulated in the cells. 3) The neutron beam causes the boron to release products such as alpha beam and lithium particles, which destroy cancer cells. 4) The alpha particles emitted destroy the cancerous cells without damaging healthy cells.
Free for anyone to re-use, but must be credited to OIST.
This work is licensed under a Creative Commons Attribution 2.0 Generic License.